Cumulative evidence suggested that increased expression levels of CXCL9 and CXCL10 induced tumor-infiltrating CD8+T cells, leading to reduced cancer progression or metastasis and enhanced survival in ovarian and colon cancer patients [66–72]. The gene discussed is CXCL10; the disease is cancer.